{"id":20805,"date":"2023-11-22T09:57:40","date_gmt":"2023-11-22T09:57:40","guid":{"rendered":"https:\/\/clinlabint.com\/?p=20805"},"modified":"2023-11-22T10:05:07","modified_gmt":"2023-11-22T10:05:07","slug":"d-dimer-fs-first-line-assay-to-diagnose-exclusion-of-thrombotic-events","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/d-dimer-fs-first-line-assay-to-diagnose-exclusion-of-thrombotic-events\/","title":{"rendered":"D-Dimer FS \u2013 first line assay to diagnose exclusion of thrombotic events"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

D-Dimer FS \u2013 first line assay to diagnose exclusion of thrombotic events<\/h1>\/ in Product News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

Thrombosis is the process of blood clot formation in blood vessels causing life-threatening \u00a0venous thromboembolic events (VTE) like a pulmonary embolism (PE).
\n<\/strong><\/h3>\n

<\/p>\n

The risk of such an event can be lowered by conducting a thromboembolism risk assessment, which in case of VTE diseases does not focus on detecting a thrombotic event rather than excluding it. The actual first-line test to rule out suspected VTE is a D-dimer assay.<\/p>\n<\/div><\/section>
\n

\"\"<\/div><\/div><\/div>
\n

With the D-Dimer FS DiaSys provides a ready-to-use particle enhanced immunoturbidimetric assay that is to be used on all clinical chemistry analyzers. The assay achieves high precision at the cut-off 0.5 \u00b5g FEU\/ml for venous thromboembolism diseases. The excellent sensitivity provides lifesaving emergency diagnostic whereas superior specificity guarantees cost saving detection. Both highlight the value of DiaSys D Dimer FS to perform reliable VTE exclusion diagnostic.<\/p>\n<\/div><\/section>
\n

\n